Advances in Chronic Kidney Disease
Volume 14, Issue 1 , Pages 75-78 , January 2007

Calcium in Chronic Kidney Disease: Recommended Intake and Serum Targets

  • Linda McCann

      Affiliations

    • Corresponding Author InformationAddress correspondence to Linda McCann, RD, CSR, LD, Satellite Healthcare, Inc, 401 Castro Street, Mountain View, CA 94041.

References 

  1. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2004;42:S1–S202
  2. In:  Olgaard K editors. Clinical Guide to Bone and Mineral Metabolism in CKD. New York, NY: National Kidney Foundation; 2006;
  3. Institute of Medicine Dietary Reference Intakes. Calcium, Phosphorus, Magnesium, Vitamin D3, and Fluoride. Washington, DC: National Academy Press; 1997;
  4. Brickman AS, Coburn JW, Massry SG, et al. 1,25 Dihydroxy-vitamin D3 in normal man and in patients with renal failure. Ann Intern Med. 1974;80:161–168
  5. Recker RR, Saville PD. Calcium absorption in renal failure: Its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables. J Lab Clin Med. 1971;78:380–388
  6. Fabrizi F, Bacchini G, Di Filippo S, et al. Intradialytic calcium balances with different calcium dialysate levels (Effects on cardiovascular stability and parathryroid function). Nephron. 1996;72:530–535
  7. Kimura K, Saika Y, Otani H, et al. Factors associated with calcification of the abdominal aorta in hemodialysis patients. Kidney Int Suppl. 1999;71:S238–S241
  8. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–1483
  9. Maher ER, Young G, Smyth-Walsh B, et al. Aortic and mitral valve calcification in patients with renal disease. Lancet. 1987;2:875–877
  10. Raggi P, Bommer J, Chertow GM. Valvular calcification in hemodialuysis patients randomized to calcium-based binders or sevelamer. J Heart Valve Dis. 2004;13:134–141
  11. Asmus HG, Braun J, Krause R, et al. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant. 2005;20:1653–1661
  12. Chertow GM, Burke SK, Raggi P Treat to Goal Work Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245–252
  13. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218
  14. Young EW, Akiba T, Albert J, et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44:S34–S38
  15. Maduell F, Gorriz JL, Pallardo LM, Pons R, Santago C. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia. J Nephrol. 2005;18:739–748

PII: S1548-5595(06)00173-X

doi: 10.1053/j.ackd.2006.10.011

Advances in Chronic Kidney Disease
Volume 14, Issue 1 , Pages 75-78 , January 2007

Article Tools